Talisman Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $526K | Sell |
2,834
-48
| -2% | -$8.91K | 0.48% | 51 |
|
|
2025
Q1 | $604K | Sell |
2,882
-147
| -5% | -$30.8K | 0.62% | 46 |
|
|
2024
Q4 | $538K | Sell |
3,029
-54
| -2% | -$9.6K | 0.57% | 48 |
|
|
2024
Q3 | $602K | Sell |
3,083
-30
| -1% | -$5.86K | 0.63% | 43 |
|
|
2024
Q2 | $534K | Buy |
3,113
+99
| +3% | +$17K | 0.62% | 43 |
|
|
2024
Q1 | $549K | Buy |
3,014
+2
| +0.1% | +$364 | 0.69% | 43 |
|
|
2023
Q4 | $467K | Buy |
3,012
+31
| +1% | +$4.8K | 0.69% | 42 |
|
|
2023
Q3 | $444K | Buy |
2,981
+70
| +2% | +$10.4K | 0.77% | 41 |
|
|
2023
Q2 | $392K | Buy |
2,911
+241
| +9% | +$32.5K | 0.67% | 47 |
|
|
2023
Q1 | $426K | Buy |
2,670
+425
| +19% | +$67.8K | 0.77% | 38 |
|
|
2022
Q4 | $363K | Buy |
+2,245
| New | +$363K | 0.77% | 41 |
|